AI compressed the build. Fundamentals matter more, not less, and the product funnel is now where engineers earn their keep.

Visitors pass in front of the Qualcomm stand at the MWC (Mobile World Congress), the world's biggest mobile fair, in Barcelona on March 4, 2025. Surrounded by investment and innovation projects, the ...

Cursor Origin git platform launched at Compile alongside a 1.5-trillion-parameter model in training and a new iOS app, as ...

Chip-design startup BoolSi Inc. today announced it has raised $6 million in seed funding to build a compiler that turns ...

Abstract: Our research focuses on the intersection of artificial intelligence (AI) and software development, particularly the role of AI models in automating code generation. With advancements in ...

Artificial intelligence (AI) has become an integral part of contemporary software engineering practice. Automated programming techniques, particularly AI-driven code generation, are increasingly used ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

Just six short years ago this week, the world shuttered. With the fear of the spread of COVID-19, restaurants closed, businesses went remote, and public spaces went eerily quiet. At universities, ...

The growing use of generative artificial intelligence (GenAI) tools for coding is transforming software engineering practices, with developers now building continuous integration and continuous ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Clarity is a statically typed language that compiles to WebAssembly, optimized for one thing: LLMs generating correct code on the first attempt. It eliminates the ambiguities and footguns that cause ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...